Young patients with STEMI ‘face high mortality risk’
Australian cardiologists have investigated post-PCI mortality outcomes by age group and MI presentation

Patients younger than 45 with ST-elevated MI (STEMI) have a higher risk of mortality after percutaneous coronary intervention (PCI) than those with non-STEMI, Victorian researchers say.
This group needs “intensive secondary prevention measures”, the team writes in the American Journal of Cardiology.